Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 4:57 PM View:  | Halozyme Therapeutics, Inc. (HALO) | 14-Aug-24 | Sale | 9,881 | $57.70 | $570,134.00 | (12%) 79.75K to 69.87K | |
| 14-Aug-24 4:57 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Aug-24 | Sale | 10,000 | $56.19 | $561,930.00 | (11%) 89.75K to 79.75K | |
| 14-Aug-24 4:57 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Aug-24 | Private Sale | 10,000 | $55.72 | $557,230.00 | (10%) 99.75K to 89.75K | |
| 13-Jun-24 4:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Jun-24 | Sale | 10,000 | $50.62 | $506,190.00 | (9%) 109.75K to 99.75K | |
| 13-Jun-24 4:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 11-Jun-24 | Private Sale | 10,000 | $50.01 | $500,110.00 | (8%) 119.75K to 109.75K | |
| 29-Apr-24 6:11 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Apr-24 | Grant | 6,501 | -- | -- | 6% 113.25K to 119.75K | |
| 05-Jun-23 6:20 PM View: | Dermtech, Inc. (DMTK) | 01-Jun-23 | Grant | 35,714 | -- | -- | 29% 122.5K to 158.22K | |
| 09-May-23 6:27 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-May-23 | Grant | 8,065 | -- | -- | 8% 105.19K to 113.25K | |
| 06-Dec-22 7:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 06-Dec-22 | Sale | 10,000 | $56.12 | $561,180.00 | (9%) 115.19K to 105.19K | |
| 06-Dec-22 7:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-Dec-22 | Sale | 10,000 | $55.74 | $557,370.00 | (8%) 125.19K to 115.19K | |
| 06-Dec-22 7:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-Dec-22 | Private Sale | 10,000 | $58.80 | $588,000.00 | (7%) 135.19K to 125.19K | |
| 31-May-22 8:11 PM View: | Dermtech, Inc. (DMTK) | 26-May-22 | Grant | 26,480 | -- | -- | 28% 96.02K to 122.5K | |
| 06-May-22 8:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-May-22 | Grant | 6,206 | -- | -- | 5% 128.98K to 135.19K | |
| 01-Dec-21 9:41 PM View: | Nautilus Biotechnology, Inc. (NAUT) | 01-Dec-21 | Market Purchase | 30,000 | $4.47 | $134,105.00 | 25% 120.0K to 150.0K | 8% |
| 01-Dec-21 9:41 PM View: | Nautilus Biotechnology, Inc. (NAUT) | 30-Nov-21 | Market Purchase | 20,000 | $4.57 | $91,400.00 | 20% 100.0K to 120.0K | 6% |
| 28-May-21 8:19 PM View: | Dermtech, Inc. (DMTK) | 26-May-21 | Grant | 9,158 | -- | -- | 11% 86.86K to 96.02K | |
| 06-May-21 8:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-May-21 | Grant | 5,230 | -- | -- | 4% 123.75K to 128.98K | |
| 19-Feb-21 6:13 PM View: | Talis Biomedical Corp (TLIS) | 17-Feb-21 | Purchase | 62,500 | $16.00 | $1,000,000.00 | 100% 0 to 62.5K | |
| 13-Jan-21 4:21 PM View: | Dermtech, Inc. (DMTK) | 11-Jan-21 | Private Purchase | 33,898 | $29.50 | $999,991.00 | 64% 52.97K to 86.86K | |
| 19-Jun-20 4:19 PM View: | Dermtech, Inc. (DMTK) | 17-Jun-20 | Grant | 8,000 | -- | -- | 18% 44.97K to 52.97K | |
| 01-May-20 7:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Apr-20 | Grant | 8,829 | -- | -- | 8% 114.92K to 123.75K | |
| 01-May-20 4:24 PM View: | Dermtech, Inc. (DMTK) | 29-Apr-20 | Option Exercise | 9,702 | $6.94 | $67,331.90 | 28% 35.26K to 44.97K | |
| 03-Feb-20 4:15 PM View: | Dermtech, Inc. (DMTK) | 30-Jan-20 | Grant | 6,000 | -- | -- | 21% 29.26K to 35.26K | |
| 03-Jan-20 4:10 PM View: | Dermtech, Inc. (DMTK) | 31-Dec-19 | Option Exercise | 15,994 | -- | -- | 121% 13.27K to 29.26K | |
| 03-May-19 4:23 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-May-19 | Grant | 12,173 | -- | -- | 12% 102.75K to 114.92K | |
| 02-May-18 7:42 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-May-18 | Grant | 10,363 | -- | -- | 11% 92.39K to 102.75K | |
| 05-May-17 4:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-May-17 | Grant | 14,135 | -- | -- | 18% 78.25K to 92.39K | |
| 06-May-16 4:58 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-May-16 | Grant | 20,202 | -- | -- | 35% 58.05K to 78.25K | |
| 07-May-15 3:47 PM View: | Halozyme Therapeutics, Inc. (HALO) | 06-May-15 | Grant | 13,175 | -- | -- | 29% 44.88K to 58.05K | |
| 14-May-14 4:42 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-May-14 | Grant | 24,876 | -- | -- | 124% 20.0K to 44.88K | |
| 30-May-13 6:29 PM View: | Illumina Inc. (ILMN) | 30-May-13 | Option Exercise | 2,836 | $37.04 | $105,045.00 | 9% 30.86K to 33.69K | |
| 30-May-13 6:29 PM View: | Illumina Inc. (ILMN) | 30-May-13 | Market Option Sale (Planned) | 2,836 | $70.80 | $200,789.00 | (8%) 33.69K to 30.86K | (323%) |
| 15-Apr-13 8:06 PM View: | Illumina Inc. (ILMN) | 11-Apr-13 | Option Exercise | 48,232 | $30.45 | $1,468,580.00 | 156% 30.86K to 79.09K | |
| 15-Apr-13 8:06 PM View: | Illumina Inc. (ILMN) | 11-Apr-13 | Market Option Sale (Planned) | 48,232 | $57.95 | $2,795,040.00 | (61%) 79.09K to 30.86K | (417%) |
| 28-Mar-13 4:53 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Mar-13 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 12-Mar-13 8:28 PM View: | Illumina Inc. (ILMN) | 08-Mar-13 | Payment of Exercise | 1,624 | $53.77 | $87,322.50 | (5%) 32.48K to 30.86K | (458%) |
| 31-Jan-13 9:33 PM View: | Illumina Inc. (ILMN) | 31-Jan-13 | Payment of Exercise | 300 | $50.63 | $15,189.00 | (< 1%) 32.17K to 31.87K | (492%) |
| 31-Jan-13 9:33 PM View: | Illumina Inc. (ILMN) | 29-Jan-13 | Grant | 4,458 | -- | -- | 16% 27.71K to 32.17K | |
| 29-Jan-13 9:18 PM View: | Illumina Inc. (ILMN) | 28-Jan-13 | Payment of Exercise | 728 | $51.62 | $37,579.40 | (3%) 28.44K to 27.71K | (481%) |
| 29-Jan-13 9:18 PM View: | Illumina Inc. (ILMN) | 27-Jan-13 | Payment of Exercise | 662 | $51.62 | $34,172.40 | (2%) 29.1K to 28.44K | (481%) |
| 13-Feb-13 8:21 PM View: | Illumina Inc. (ILMN) | 01-Aug-12 | Acquisition (other) | 26 | $35.62 | $926.21 | < 1% 29.1K to 29.13K | |
| 12-Mar-12 9:32 PM View: | Illumina Inc. (ILMN) | 08-Mar-12 | Grant | 12,292 | -- | -- | 73% 16.81K to 29.1K |